Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329

Watchlist Manager
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Watchlist
Price: 31.44 CNY 0.48% Market Closed
Market Cap: 24.2B CNY

Intrinsic Value

The intrinsic value of one Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock under the Base Case scenario is 37.2 CNY. Compared to the current market price of 31.44 CNY, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is Undervalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
37.2 CNY
Undervaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
CN
Pharmaceuticals
Market Cap
24.2B CNY
IPO
Jun 6, 2001
CN
Pharmaceuticals
Market Cap
24.2B CNY
IPO
Jun 6, 2001
Price
ÂĄfalse
EPS
ÂĄfalse
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Current Assets 7.1B
Cash & Short-Term Investments 1.5B
Receivables 2.9B
Other Current Assets 2.8B
Non-Current Assets 3.8B
Long-Term Investments 942.1m
PP&E 1.5B
Intangibles 371m
Other Non-Current Assets 1.1B
Efficiency

Free Cash Flow Analysis
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Revenue
8B CNY
Cost of Revenue
-4.4B CNY
Gross Profit
3.7B CNY
Operating Expenses
-2.9B CNY
Operating Income
793.6m CNY
Other Expenses
138.7m CNY
Net Income
932.4m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive Revenue Growth Forecast
55/100
Profitability
Score

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
70/100
Solvency
Score

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Wall Street analysts forecast Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 46.72 CNY with a low forecast of 46.26 CNY and a high forecast of 48.09 CNY.

Lowest
Price Target
46.26 CNY
47% Upside
Average
Price Target
46.72 CNY
49% Upside
Highest
Price Target
48.09 CNY
53% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock?

The intrinsic value of one Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock under the Base Case scenario is 37.2 CNY.

Is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock undervalued or overvalued?

Compared to the current market price of 31.44 CNY, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is Undervalued by 15%.

Back to Top